Gimv NV: history, ownership, mission, how it works & makes money

Founded in 1980, Gimv NV has evolved into a pan-European investor that today manages around 60 companies generating a combined turnover of €4.5 billion and employing more than 20,000 people, underpinned by a strategic focus on five sectors-Consumer, Healthcare, Life Sciences, Smart Industries and Sustainable Cities-and an investment ticket range of €5 million to €150 million; recent milestones include a February 2025 rights issue that raised €243 million, the October 2025 exit of Imcheck Therapeutics to Ipsen, a November 2025 minority investment in Quality Guard, and a portfolio valuation peak of €2 billion in November 2025, while its shareholder base is led by WorxInvest NV with 35.44% ownership as of 30 July 2025 and a public free float of 64.56%, reflecting a governance mix that supports Gimv's mission to back high‑growth entrepreneurs with patient capital, active partnerships and sustainability-driven value creation

Gimv NV (GIMB.BR): Intro

• Founded: 1980 (Belgium)
• Listing: Euronext Brussels (ticker GIMB.BR)
• Investment focus: Life Sciences, Technology, Sustainable Cities, Consumer & Healthcare, and Industrial/Business Services
• Portfolio (Dec 2025): ~60 companies
• Combined turnover of portfolio companies (Dec 2025): €4.5 billion
• Employees across portfolio (Dec 2025): >20,000

• 1980-2000: Establishment and expansion in Belgian and Western European private equity markets.
• 2000-2015: Diversification into sector funds and increasing emphasis on growth capital and internationalization.
• 2016-2024: Strengthening sector-focused teams (Life Sciences, Tech, Smart Industries, Sustainable Cities) and selective cross-border investments.
• 2025: Capital strengthening via €243m rights issue (Feb 2025); material realization (Imcheck → Ipsen, Oct 2025); strategic minority stake in Quality Guard (Nov 2025).

• Public ownership: Listed entity with a broad shareholder base on Euronext Brussels.
• Governance: Board of Directors and an executive management team responsible for investment strategy, risk management and value creation across portfolio companies.
• Capital base (post-Feb 2025 rights issue): strengthened equity to support new investments and follow-ons.

• Mission: To build and scale European companies with sustainable growth and international reach by combining capital, sector expertise and active board-level involvement.
• Vision: Long-term value creation through selective investments in innovative companies that can lead their markets.
• Core values: Entrepreneurial partnership, sector specialization, responsible investment and active value creation.

• Investment approach: Sector-focused teams source and diligente opportunities across growth, buy-out and venture stages; typical involvement includes board seats, strategic guidance and support for international scaling.
• Deal types: Minority and majority stakes, structured growth investments, buy-outs and co-investments with other private equity players.
• Value creation: Operational support, commercial scaling, follow-on capital, M&A facilitation and professionalization of management teams.

• Capital gains on realisations: Primary driver-exiting portfolio companies via trade sales, IPOs or secondary sales (e.g., Imcheck → Ipsen exit in Oct 2025).
• Dividend and recurring income: Distributions from profitable portfolio companies.
• Net asset value (NAV) growth: Appreciations in fair value of held investments are reflected in NAV, which drives shareholder value for a listed investment company.
• Fund and advisory fees: For certain structured funds or mandate-based activities, fees and carried interest contribute to revenue (where applicable).
• Liquidity events and rights issuances: Capital raises (e.g., €243m rights issue, Feb 2025) support new investments and can affect financing cost and return profile.

Gimv NV (GIMB.BR): History

• Listed: Euronext Brussels - ticker GIMB
• Largest shareholder (as of 30 July 2025): WorxInvest NV - 35.44% of shares
• Free float (as of 30 July 2025): 64.56%
• Transparency regime: statutory notification threshold 3% of voting rights; notifications required for holdings exceeding 3%

• Shareholder mix: combination of institutional investors and public (retail) holders - governance influenced by both concentrated strategic investor (WorxInvest) and broad free float
• Regulatory implications: holdings above 3% trigger mandatory disclosure under Gimv's articles and Belgian transparency rules; this fosters market visibility into changes in control or influence
• Impact on strategy: a ~35.4% cornerstone holder provides strategic continuity, while the 64.56% free float maintains market liquidity and public governance oversight

Gimv NV (GIMB.BR): Ownership Structure

• Mission: Identify and back entrepreneurial, innovative companies to become market leaders using patient capital and a long-term view.
• Values: Innovation, entrepreneurship, sustainable growth, and partnership with management teams.
• Sustainability: Integrated as a core investment driver to enhance long-term value and societal impact.
• Investment focus: Consumer, Healthcare & Life Sciences, Smart Industries, Sustainable Cities.

• Realization gains from exits: trade sales, secondary sales and IPOs of portfolio companies.
• Value uplift: active value creation (operational improvements, scaling, add‑on acquisitions) that increases fair value of holdings.
• Dividend and interest income from certain portfolio positions.
• Management fees and carried interest on managed funds and co-investments (where applicable).

• Maintains a solid balance sheet with access to committed credit lines and listed equity to provide patient capital for growth rounds and follow‑ons.
• Co-investment by management and alignment mechanisms to ensure long-term partnership with founders and management teams.

• Sector teams provide hands-on operational support, strategic guidance, internationalisation and access to networks to accelerate scale-up.
• Sustainability and ESG integration across due diligence and portfolio value creation plans to enhance competitiveness and resilience.

Gimv NV (GIMB.BR): Mission and Values

• Consumer
• Healthcare
• Life Sciences
• Smart Industries
• Sustainable Cities

• Sector funneling: sourcing entrepreneurial and innovative companies with high-growth potential within the five platforms, largely in the Benelux, France and DACH regions.
• Flexible ticketing: making equity investments generally ranging from €5 million to €150 million depending on stage, from venture/growth rounds to buyouts.
• Investment types: deploying venture capital, growth capital and buyout transactions tailored to company maturity and capital needs.
• Active partnership: providing capital plus strategic guidance, board-level support, international commercial and operational expertise, and access to a network of domain experts and corporates.
• Sustainability & ESG: integrating ESG due diligence and value creation plans to enhance resilience and meet stakeholder expectations.

• Sourcing: targeted sector scouting and proprietary deal flow in Benelux, France and DACH; co-investments with international funds where appropriate.
• Due diligence & structuring: commercial, technical and financial DD, followed by flexible structuring (minority growth stakes to full buyouts).
• Scaling: support in international expansion, digital transformation, M&A add-ons and professionalization of management and governance.
• Exit: timed disposals via trade sale, secondary sale or IPO to realize returns and recycle capital into new opportunities.

• Realized gains from exits: proceeds when portfolio companies are sold or listed.
• Dividend and recurring income: dividends or distributions from mature portfolio companies.
• Management and performance-related fees (for closed-end funds) and capital appreciation reflected in the listed vehicle's NAV.

• Scaling commercial footprint: using international sales networks to grow cross-border revenue and prepare companies for trade-sale to strategic acquirers.
• Operational improvements: driving productivity, digitization and margin expansion in Smart Industries and Sustainable Cities portfolio companies.
• R&D and regulatory support: accelerating clinical or product development in Healthcare and Life Sciences with capital and access to specialist advisors.

• Active board involvement: Gimv typically takes board seats to co-drive strategy with management teams.
• Aligned incentives: equity-based remuneration and co-investment with founders/management to align long-term interests.
• ESG oversight: integration of sustainability KPIs into monitoring and reporting.

Gimv NV (GIMB.BR): How It Works

• Primary sectors: Health & Care, Smart Industries, Sustainable Cities, and Consumer & Leisure.
• Stage focus: Growth capital and buy‑ins for scaling companies (typically revenue‑generating, EBITDA positive or near break‑even).
• Geographic focus: Benelux and broader Western Europe with selective global exposures.

• Capital gains on exits - realized profits when portfolio companies are sold (trade sale, secondary buyout, IPO).
• Management fees - recurring fees charged for managing third‑party funds and dedicated mandates.
• Dividends - cash distributions received from profitable portfolio companies.
• Interest income - interest on shareholder loans and convertible instruments provided to portfolio companies.
• Performance fees / carried interest - a share of outperformance delivered to third‑party investors in certain fund structures.

• Portfolio valuation growth: unrealized revaluations feed the income statement through fair value gains (impacting reported net result and equity).
• Exit cadence: the timing and multiples of disposals determine realized capital gains and cash generation.
• Fee mix: a higher proportion of AUM from third‑party capital increases predictable management fee income versus more volatile investment income.
• Dividend policy of portfolio companies: regular dividends provide recurring cash yield that can be distributed to shareholders or re‑invested.

• Origination: sector teams source and screen growth companies with differentiated propositions.
• Investment: structuring of minority/majority stakes, often combining equity, shareholder loans, and performance‑linked instruments.
• Value creation: operational support (commercial scaling, international expansion, governance), board involvement and follow‑on financing.
• Exit: sale to strategic buyer, financial buyer or IPO; realized proceeds drive capital gains and cash returns.

• Market exits and valuations - weaker M&A/IPO markets compress realized gains and fair‑value uplift.
• Portfolio performance - company-level operational setbacks reduce dividends, interest receipts and valuation uplift.
• Fundraising success - ability to attract third‑party capital sustains fee income and co‑investment opportunities.
• Concentration and sector cycles - while diversified, sector downturns (e.g., industrials, consumer) can affect near‑term returns.

• Investors in Gimv benefit from both capital appreciation on Gimv's balance‑sheet holdings and recurring fee income from asset management activities.
• Management teams are often incentivized through carry arrangements and co‑investment, aligning interests toward value creation and exit outcomes.

Gimv NV (GIMB.BR): How It Makes Money

• Primary revenue and return sources: exit proceeds from trade sales and IPOs, dividend income from portfolio companies, and value appreciation recorded in net asset value (NAV).
• Fee income: management fees and performance-linked incentives for third-party mandates and co-investment structures.
• Capital recycling: proceeds from realizations are redeployed into new investments, amplified by the February 2025 capital increase that strengthened acquisition capacity.

• Competitive positioning: strong European presence, diversified portfolio, and an explicit sustainability & innovation mandate.
• Future outlook: positive - robust balance sheet post-February 2025 capital increase, high portfolio valuation, and clear growth strategy to capture emerging market opportunities.